Closed |
S1014 |
Metastatic PCa Suboptimal Response ADT, Abiraterone Acetate, Ph II |
8/9/2011 |
8/1/2013 |
98% |
|
Published
|
Closed |
S1106 |
Randomized Phase II Younger Patients Mantle Cell Lymphoma |
10/1/2011 |
6/26/2013 |
29% |
|
Published
|
Closed |
S0927 |
Ph III Omega-3 fatty acid/placebo Breast Cancer |
2/1/2012 |
2/1/2013 |
100% |
|
Published
|
Closed |
S1108 |
Phase II MLN8237 in Peripheral T-Cell NHL |
10/28/2011 |
6/6/2013 |
100% |
|
Published
|
Closed |
S1119 |
Water Contamination Study |
12/2/2011 |
8/5/2013 |
100% |
|
Published
|
Closed |
S1117 |
Rando PII Aza vs. Aza/Len vs. Aza/Vorin for High Risk MDS and CMML |
3/1/2012 |
11/14/2014 |
100% |
|
Published
|
Closed |
S1115 |
Rando Phase II of AZD-6244 add MK-2206 vs mFOLFOX in Pts with Met Pancreatic Cancer After Chemo |
8/15/2012 |
5/15/2014 |
100% |
|
Published
|
Closed |
S1202 |
Ph III Study of Duloxetine for AI-associated musculoskleteal symptoms for Early Stage BrCa |
5/15/2013 |
10/1/2015 |
100% |
|
Published
|